Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glycolysis: Pay-off Phase01:25

Glycolysis: Pay-off Phase

12.6K
So far, glycolysis has cost the cell two ATP molecules and produced two small, three-carbon sugar molecules. These molecules will proceed through the second half of the pathway, and sufficient energy will be extracted to pay back the two ATP molecules used as an initial investment and produce a profit for the cell of two additional ATP molecules and two even higher-energy NADH molecules.
Step 1 - 5: Glycolysis Preparatory Phase
The first phase of glycolysis has 5 steps where the glucose is...
12.6K
Structural Joints: Synovial Joints01:16

Structural Joints: Synovial Joints

7.0K
Synovial joints are the most common type of joint in the body. A key structural characteristic for a synovial joint is the presence of a joint cavity. This fluid-filled space is where the articulating surfaces of the bones contact each other. Also, unlike fibrous or cartilaginous joints, the articulating bone surfaces at a synovial joint are not directly connected to each other with fibrous connective tissue or cartilage. This gives the bones of a synovial joint the ability to move smoothly...
7.0K
Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

2.4K
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
2.4K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.3K
Overview
80.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
Heat Engines01:10

Heat Engines

3.7K
A heat engine is a device used to extract heat from a source and then convert it into mechanical work used for various applications. For example, a steam engine on an old-style train can produce the work needed for driving the train.
Whenever we consider heat engines (and associated devices such as refrigerators and heat pumps), we do not use the standard sign convention for heat and work. For convenience, we assume that the symbols Qh, Qc, and W represent only the amounts of heat transferred...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LPAR4 mediates resistance to interferon-induced stress in soft tissue sarcoma.

Science advances·2026
Same author

Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States.

bioRxiv : the preprint server for biology·2026
Same author

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.

Annals of surgical oncology·2026
Same author

Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study.

Cancer discovery·2026
Same author

Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuits.

bioRxiv : the preprint server for biology·2026
Same author

ASO Visual Abstract: Timing and Frequency of Surveillance After Resection of Extremity and Trunk Soft Tissue Sarcoma-Identifying Opportunities for Improvement.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Feb 7, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Engineered T Cells in Synovial Sarcoma: Persistence Pays Off!

Emily Z Keung1, Hussein A Tawbi2

  • 1Divison of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Discovery
|August 5, 2018
PubMed
Summary

Adoptive T-cell therapy targeting the NY-ESO-1 antigen shows promise for synovial sarcoma (SS). This approach engineers a patient

More Related Videos

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
09:58

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

21.3K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

6.3K

Related Experiment Videos

Last Updated: Feb 7, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
09:58

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

21.3K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

6.3K

Area of Science:

  • Oncology
  • Immunotherapy

Background:

  • Synovial sarcoma (SS) is an aggressive cancer affecting young adults with poor prognosis.
  • Existing treatments like immune checkpoint blockade have limited efficacy for SS.
  • Cancer testis antigens, such as NY-ESO-1, present potential therapeutic targets.

Purpose of the Study:

  • To evaluate the safety and feasibility of adoptive T-cell therapy (ACT) using NY-ESO-1-targeted autologous T cells in patients with SS.

Main Methods:

  • Engineering autologous T cells to express a T-cell receptor (TCR) specific for the NY-ESO-1 antigen.
  • Administering these engineered T cells to patients with advanced SS.

Main Results:

  • The study confirmed the safety and feasibility of this adoptive T-cell therapy approach.
  • Encouraging preliminary results suggest potential efficacy in treating SS.

Conclusions:

  • Adoptive T-cell therapy targeting NY-ESO-1 is a safe and feasible strategy for synovial sarcoma.
  • This immunotherapy approach warrants further investigation for advanced SS treatment.